Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Clin Infect Dis. 2017 Oct 1;65(7):1085–1093. doi: 10.1093/cid/cix505

Figure 1. Profile of Persons with Latent TB Infection Who Took 3HP.

Figure 1

aTreatment reason per local policy are dichotomous factors: therefore, n does not equal 3288

bRecent contact of person with contagious TB

cPerson with baseline tuberculin skin test who has ≥10mm increase in induration, or positive IGRA with a documented negative TB test, within a 2-year period

Abbreviations: 3HP, a 3-month regimen of isoniazid and rifapentine; HAART, highly active antiretroviral treatment; HIV, human immunodeficiency virus; IGRA, interferon-gamma release assay; LTBI, latent tuberculosis infection; TB, tuberculosis.